Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.

A series of hydrochloride derivatives 2a-9a and quaternary ammonium derivatives 3b-9b of diphenidol have been synthesized and characterized in receptor binding and cellular functional assays versus human muscarinic M(1)-M(5) receptors expressed in CHO cells. Compound 8b, a methiodide derivative with a bipiperidinyl moiety and a second diphenidol framework, showed a potent and selective M(4) activity as competitive antagonist. Moreover 8b, acting as an allosteric modulator, was able to retard the dissociation rate of [(3)H]-N-methylscopolamine from CHO-M(4) cell membranes exposed to atropine. Taken together, these data suggest that 8b might open new avenues to the discovery of novel multivalent antagonists for the muscarinic receptors.

[1]  Richard M. Eglen,et al.  Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development , 2007, Nature Reviews Drug Discovery.

[2]  T. Manabe,et al.  Roles of M2 and M4 muscarinic receptors in regulating acetylcholine release from myenteric neurons of mouse ileum. , 2005, Journal of neurophysiology.

[3]  P. Sexton,et al.  Interaction Studies of Multiple Binding Sites on M4 Muscarinic Acetylcholine Receptors , 2006, Molecular Pharmacology.

[4]  M. Scheinin,et al.  Nonradioactive GTP binding assay to monitor activation of g protein-coupled receptors. , 2003, Assay and drug development technologies.

[5]  M. Mammen,et al.  A Novel Multivalent Ligand That Bridges the Allosteric and Orthosteric Binding Sites of the M2 Muscarinic Receptor , 2007, Molecular Pharmacology.

[6]  J. Wess.  Novel insights into muscarinic acetylcholine receptor function using gene targeting technology. , 2003, Trends in pharmacological sciences.

[7]  Aalt Bast,et al.  Comprehensive medicinal chemistry , 1991 .

[9]  J. Wess,et al.  Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice , 2003, Molecular Psychiatry.

[10]  H. Zaugg,et al.  Tertiary Carbinols of the Piperazine Series. I , 1958 .

[11]  E. Kostenis,et al.  Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation. , 1996, Trends in pharmacological sciences.

[12]  T. Kenakin,et al.  G Protein-Coupled Receptor Allosterism and Complexing , 2002, Pharmacological Reviews.

[13]  U. Holzgrabe,et al.  Allosteric modulators of ligand binding to muscarinic acetylcholine receptors , 1998 .

[14]  T. Mamiya,et al.  Effects of anticholinergic drugs selective for muscarinic receptor subtypes on prepulse inhibition in mice. , 2004, European journal of pharmacology.

[15]  C. Kaiser,et al.  Analogs of phenothiazines. 4. Effect of structure upon neuropharmacological activity of some chlorpromazine analogs of the diphenylmethane type. , 1972, Journal of medicinal chemistry.

[16]  M. Recanatini,et al.  Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2-carbonyl derivatives of diphenidol. , 1999, Bioorganic & medicinal chemistry.

[17]  C. Kaiser,et al.  Synthesis and antimuscarinic activity of some 1-cycloalkyl-1-hydroxy-1-phenyl-3-(4-substituted piperazinyl)-2-propanones and related compounds. , 1993, Journal of medicinal chemistry.

[18]  T. Pugsley,et al.  Synthesis and pharmacology of benzoxazines as highly selective antagonists at M4 muscarinic receptors , 2002 .

[19]  S. Reina,et al.  Neuronal nitric oxide synthase activity in rat urinary bladder detrusor: participation in M3 and M4 muscarinic receptor function. , 2005, Autonomic & autacoid pharmacology.

[20]  Beat Ernst,et al.  Drug discovery today. , 2003, Current topics in medicinal chemistry.

[21]  A. Cavalli,et al.  Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol. , 2003, Farmaco.